Skip to main content
Ovation Science Inc. logo

Ovation Science Inc. — Investor Relations & Filings

Ticker · OVAT ISIN · CA69016D1087 LEI · 549300A1P7L8HTTQXY56 CSE Professional, scientific and technical activities
Open in API
Filings indexed 252 across all filing types
Latest filing 2021-05-01 Audit Report / Informat…
Country CA Canada
Listing CSE OVAT

About Ovation Science Inc.

https://ovationscience.com/

Ovation Science Inc. is a research and development company specializing in advanced topical and transdermal product formulations. The core technology is Invisicare®, a patented, high-performance drug delivery system engineered to enhance the penetration and efficacy of active ingredients, particularly cannabis and hemp-derived cannabinoids (CBD, THC, CBN, CBG). Ovation utilizes pharmaceutical protocols to develop these formulations. Its primary business model involves licensing the Invisicare® technology and proprietary formulations to international partners for manufacturing and market distribution. The company also distributes finished topical CBD products under proprietary brands, such as the Invibe® MD wellness line and ARLO CBD Beauty anti-aging line, all leveraging the unique delivery capabilities of Invisicare®.

Recent filings

Filing Released Lang Actions
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 100% confidence The document is titled 'INDEPENDENT AUDITOR'S REPORT' and contains an auditor's opinion on the consolidated financial statements of Ovation Science Inc. for the years ended December 31, 2020 and 2019. It includes detailed financial statements such as the consolidated statements of financial position, loss and comprehensive loss, changes in shareholders' equity, and cash flows, along with notes to the financial statements. The presence of an auditor's report with detailed financial data and accounting policies indicates this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), and it contains actual financial data and audit opinions, not merely an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2020
2021-05-01 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management Discussion & Analysis For the years ended December 31, 2020 and 2019' and contains detailed narrative about the company's business, regulatory environment, forward-looking statements, and operational context. It references preparation in accordance with National Instrument 51-102 and IFRS standards, typical for MD&A sections accompanying annual financial statements. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. There is no indication that this is a standalone audit report, earnings release, or other specific filing type. The content matches the typical Management Discussion and Analysis report, which provides management's detailed explanation of financial results, business trends, and outlook. Therefore, the appropriate classification is Management Reports (MDA).
2021-05-01 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings for a Venture Issuer, signed by the CEO certifying the review and fair presentation of the annual filings for the financial year ended December 31, 2020. It is primarily an officer certification letter confirming the accuracy and completeness of the annual filings, including the annual financial statements and MD&A. The document does not contain the actual financial statements or substantive financial data but is a certification related to those filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K) or other financial reports.
2021-05-01 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings for a venture issuer, signed by the CFO, certifying the review and fair presentation of the annual filings for the financial year ended December 31, 2020. It explicitly states it is a certification related to annual filings, not the filings themselves. The document is short (3124 characters) and primarily an officer certification letter. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K) or other financial reports. Therefore, the correct classification is Regulatory Filings (RNS).
2021-05-01 English
News release - English.pdf
Regulatory Filings
2021-04-27 English
News release - English.pdf
Regulatory Filings
2021-04-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.